<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362757">
  <stage>Registered</stage>
  <submitdate>13/07/2012</submitdate>
  <approvaldate>16/07/2012</approvaldate>
  <actrnumber>ACTRN12612000753853</actrnumber>
  <trial_identification>
    <studytitle>Effect of potassium supplementation on blood vessel function</studytitle>
    <scientifictitle>Acute effect of potassium supplementation on endothelial function in healthy populations</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cardiovascular disease</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Potassium supplemented soup meal (36mmol potassium) to be consumed within 15minutes versus control with 7day washout between visits </interventions>
    <comparator>Regular potassium soup meal (6mmol potassium) to be consumed within 15minutes</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Brachial artery flow mediated dilatation (FMD) - percentage of dilatation</outcome>
      <timepoint>measured at 30min intervals for 2hours postprandially</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>BMI greather than 18kg/m2 and less than 27kg/m2
SBP &lt;90mmHg DBP&lt;130mmHg
weight stable for 6months</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Use of antihypertensive medication, systemic steroids, folate supplementation or non-steroidal antiinflammatory
drugs.
Metabolic disease such as liver or kidney disease.
Treated hypertension.
Previous clinical cardiovascular disease.
Unable to comprehend protocol.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The study will be advertised publicly. Participants will be enrolled and randomised to treatement order after screening. Treatment concealment is by coded containers that are administed to participants by a person independent to the study.</concealment>
    <sequence>The participants are assigned treatment order using a numbered random-allocation sequence generated by
using a computer program (CLINSTAT software) by a person independent to the study.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>30/07/2012</anticipatedstartdate>
    <actualstartdate>8/08/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>16/11/2012</actualenddate>
    <samplesize>32</samplesize>
    <actualsamplesize>32</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>7/12/2012</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of South Australia</primarysponsorname>
    <primarysponsoraddress>City East Campus
University of South Australia
GPO Box 2471
Adelaide
SA 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of South Australia</fundingname>
      <fundingaddress>City East Campus
University of South Australia
GPO Box 2471
Adelaide
SA 5000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine the effect of potassium supplementation in a single meal on blood vessel function.  A high potassium intake is associated with reduced risk of heart disease however effect of potassium on blood vessel function is not known. We propose potassium supplementation will improve blood vessel function.</summary>
    <trialwebsite />
    <publication>Blanch N, Clifton PM, Keogh JB. Postprandial effects of potassium supplementation on vascular function and blood pressure: a randomised cross_over study. Nutrition, Metabolism and Cardiovascular Diseases. 2014;24(2):148-54. (IF 3.875)</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of South Australia Human Research Ethics Committee</ethicname>
      <ethicaddress>PO Box 2471
Adelaide 
SA 5001</ethicaddress>
      <ethicapprovaldate>11/07/2012</ethicapprovaldate>
      <hrec>0000028282</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Associate Professor Jennifer Keogh</name>
      <address>University of South Australia
City East Campus 
North Terrace 
Adelaide SA 5000</address>
      <phone>+61 8 8302 2579</phone>
      <fax />
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Associate Professor Jennifer Keogh</name>
      <address>University of South Australia
City East Campus 
North Terrace 
Adelaide SA 5000</address>
      <phone>+61 8 8302 2579</phone>
      <fax />
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Associate Professor Jennifer Keogh</name>
      <address>University of South Australia City East Campus North Terrace Adelaide SA 5000 </address>
      <phone>+61 8 8302 2579</phone>
      <fax />
      <email>jennifer.keogh@unisa.edu.au </email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>